SCIENTIFIC EVIDENCE

Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma

International journal of nanomedicine

Cao M, Zhan M, Wang Z, Wang Z, Li XM, Miao M.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2020

Cell Counting & Viability

Key Finding

This study examines drug formulation and delivery of isoliquiritigenin.

Countstar Connection

The researchers counted cells with the Countstar IC1000.

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online